Providence Medical Technology, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Providence Medical Technology, Inc. - overview
Established
2008
Location
Pleasanton, CA, US
Primary Industry
Medical Devices & Equipment
About
Providence Medical Technology, Inc. is focused on designing and manufacturing innovative spinal medical devices to enhance surgical outcomes in spinal fusion procedures, particularly for high-risk patients. Founded in 2008 and headquartered in Pleasanton, US, Providence Medical Technology, Inc. is engaged in the development of advanced spinal devices.
The company has successfully completed 11 deals, with its most recent funding round being a Series G in August 2018, where it raised USD 21. 00 mn led by Revelation Capital Management. The company was co-founded by Bruce McCormack and Jeff Smith, who is also the current CEO. Providence Medical Technology, Inc.
specializes in developing innovative spinal devices, focusing on posterior cervical and lumbar fusion procedures. Their flagship product, the CORUS™ PCSS, is FDA cleared for multi-level circumferential cervical fusion, addressing challenges faced by high-risk patients such as those with diabetes and osteoporosis. The company primarily markets its products to hospitals and surgical centers in the United States, facilitating cervical spine surgeries. The revenue structure of Providence Medical Technology, Inc.
comes from direct sales of their medical devices to healthcare facilities, including bulk purchasing agreements. These transactions involve hospitals acquiring the CORUS™ PCSS and related devices for surgical procedures, with pricing influenced by procedure complexity and volume. This model supports the company's focus on improving clinical outcomes for high-risk patients in the spinal care market. Providence Medical Technology, Inc.
plans to utilize the USD 21. 00 mn raised in its Series G funding round to support the development of new products and enhance its market presence. The company is focused on expanding its offerings in spinal devices and may explore opportunities in international markets to reach new healthcare providers. The recent funding will aid in refining product designs and facilitate entry into additional geographic regions.
Current Investors
MVM Partners, Aphelion Capital, Medvest Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.providencemt.com
Verticals
HealthTech
Company Stage
Series G
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.